20273 results for «»
20273 results
PCR London Valves 2019: Programme highlights

TAVI in unusual clinical situations
19 Nov 2019 – From PCR London Valves 2019
Consult this session to discover various interesting cases, involving TAVI in unusual clinical situations, such as in long-term ventricular assist device supported patient, in pure aortic regurgitation and advanced liver and kidney failure, and more!

Prosthesis-patient mismatch following transcatheter aortic valve replacement with supra-annular and intra-annular prostheses
03 Dec 2019
The results of this study suggest that the use of self-expandable valves could help reduce the incidence of post-procedural PPM after TAVI, especially in the population with large body size...

Reviewer

Reviewer

Souheib Feliachi
Brest, France

PCR Webinars: a perfect complement to EuroPCR!
15 Sep 2025 - 15 Sep 2025

Irfan Bhat
Dehradun, India
Sivaramakrishnan Manoj
Mahmoud Traina
Abu Dhabi, United Arab Emirates
Femoral versus nonfemoral peripheral access for transcatheter aortic valve replacement
05 Dec 2019
Using the data from the national prospective French registry (FRANCE TAVI), this study compared the characteristics and outcomes of TAVR procedures according to whether they were performed through a femoral or a nonfemoral peripheral access.

Reviewer

Khaleel Syed Abdul Khadar
Salem, India
Reduced leaflet motion after transcatheter aortic-valve replacement
27 Nov 2019
The GALILEO-4D was a dedicated substudy that sought to evaluate the effect of oral anticoagulation with rivaroxaban on bioprosthetic aortic valve leaflet thickening and motion impairment.

Reviewer

Reviewer

Reda Abuelatta
Medina, Saudi Arabia
Concetta Mammone
Verona, Italy

Optimal strategy for antiplatelet therapy after endovascular revascularization for lower extremity peripheral artery disease
15 Jan 2020
The aim of this study was to examine the optimal strategy for antiplatelet therapy for patients with lower extremity peripheral artery disease (PAD) following endovascular repair

Reviewer

Ching Wei Lee
TAIPEI
Pierfrancesco Corvo
RAs Al Khaimah, United Arab Emirates
Mohamed Abdelwahab Adel
Cairo, Egypt
Ashraf Abdelsalam
Kuwait, Kuwait
A controlled trial of rivaroxaban after transcatheter aortic-valve replacement (GALILEO)
13 Dec 2019
The GALILEO trial was a randomized, open-label, event-driven, international, multicentre trial comparing two different preventive strategies for thromboembolic complications in patients who underwent successful TAVI and had not established indication for oral anticoagulation.

Reviewer

Reviewer

Eduardo Bahena-López
Mexico City, Mexico
